Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention Cosmo GodinoAntonio ColomboAlberto Margonato Review Article 21 October 2016 Pages: 105 - 120
Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies Rezarta CuniIris ParriniMaria Rosa Conte Review Article 14 September 2016 Pages: 121 - 134
Adverse Events and Efficacy of Cixutumumab in Phase II Clinical Trials: A systematic Review and Meta-Analysis Hongxin CaoLixuan CuiJiajun Du Systematic Review 17 November 2016 Pages: 135 - 153
Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis Wei XuYang GongCuiju Tang Original Research Article 24 September 2016 Pages: 155 - 165
Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Hui LiuRong FuZonghong Shao Original Research Article 08 October 2016 Pages: 167 - 174
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study Veronika TicháRoman KodýmPavla Kadlecová Original Research Article Open access 26 October 2016 Pages: 175 - 186
Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration Weijun GuoWenlin LuQingyun Zhao Original Research Article 26 October 2016 Pages: 187 - 193
Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers Srini RamanathanJulie A. Di PaoloBrian P. Kearney Original Research Article Open access 26 October 2016 Pages: 195 - 205
Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study Yuri Aleksandrovich KarpovOn behalf of the FORTISSIMO physicians Original Research Article 22 November 2016 Pages: 207 - 217